Estrogens and Related Drugs

Estrogens and Related Drugs

Overview of Estrogens and Related Drugs

  • Estrogens are hormones involved in female reproductive health.

  • Related drugs include antiestrogens, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and various synthetic and natural estrogens.

Categories of Estrogens

  • Natural (Endogenous)

    • Examples: Estradiol (17β-estradiol), Estrone, Estriol

    • Source: Produced by ovaries; Estradiol is the most potent, Estriol is the weakest and is higher in pregnancy.

  • Synthetic Estrogens

    • Steroidal: Ethinyl Estradiol (common in OCPs), Mestranol (prodrug), Estradiol Valerate.

    • Non-Steroidal: Diethylstilbestrol (historically significant, teratogenic).

  • Conjugated Estrogens

    • Example: Conjugated Equine Estrogens (CEE) used in hormone replacement therapy (HRT).

Drug Profile Examples

  • Estrogens include natural and synthetic forms.

  • SERMs such as Tamoxifen (antagonist in breast, agonist in bone), Raloxifene (agonist in bone, antagonist in breast).

  • Clomiphene Citrate (antagonist in the hypothalamus).

General Mechanism of Action of Estrogens

  1. Target: Estrogen Receptors (ER-α and ER-β)

  2. Process:

    • Estrogen diffuses into the cell and binds to the receptor.

    • The hormone-receptor complex dimerizes and enters the nucleus.

    • It binds to Estrogen Response Elements (ERE) on DNA.

  3. Result: Modulation of gene transcription increases synthesis of specific proteins (e.g., progesterone receptors, clotting factors).

  4. Physiological Effects:

    • Development of female secondary sex characteristics.

    • Proliferation of endometrium during the menstrual cycle.

    • Maintenance of bone density.

    • Feedback on hypothalamus/pituitary.

Individual Drug Profiles

Ethinyl Estradiol (EE)

  • Indications:

    • Combined Oral Contraceptives (COCs).

    • Emergency Contraception (e.g., Yuzpe regimen).

    • Dysfunctional Uterine Bleeding (DUB).

    • Hypoestrogenism (e.g., Turner syndrome).

  • Doses:

    • Contraception: 20–35 mcg; emergency: 100 mcg + 0.5 mg levonorgestrel.

  • Mechanism of Action:

    • Suppresses FSH and LH to prevent ovulation.

    • Stabilizes endometrium, preventing breakthrough bleeding.

  • Contraindications: (ACHES)

    • Age >35 with smoking history.

    • Current or past breast cancer (hormone-sensitive).

    • Uncontrolled hypertension.

    • Estrogen-dependent tumors.

    • Systemic diseases (liver disease, thrombophilia, migraines with aura).

  • Drug Interactions:

    • Enzyme inducers decrease efficacy (e.g., Rifampicin, Carbamazepine).

    • Antibiotics may disrupt enterohepatic circulation.

  • Side Effects:

    • Common: Nausea, breast tenderness, breakthrough bleeding, headache, melasma.

    • Serious: Increased risk of DVT, PE, stroke, myocardial infarction.

Conjugated Estrogens

  • Indications:

    • Hormone Replacement Therapy (HRT) for menopausal symptoms.

    • Prevention of postmenopausal osteoporosis.

    • Female hypogonadism.

  • Doses:

    • Oral: 0.3–1.25 mg/day;

    • Vaginal cream for atrophic vaginitis.

  • Mechanism of Action:

    • Replaces declining endogenous estrogen levels.

  • Contraindications:

    • Similar to Ethinyl Estradiol; also avoid in pregnancy.

  • Drug Interactions:

    • Similar to Ethinyl Estradiol.

  • Side Effects:

    • Similar thromboembolism risks; unopposed estrogen raises risk of endometrial hyperplasia.

ESTRIOL

  • Indications:

    • Topical treatment for atrophic vaginitis/genitourinary syndrome of menopause (GSM).

  • Doses:

    • Vaginal formulations; low dose and minimally absorbed.

  • Mechanism of Action:

    • Weak estrogen; binds to local receptors in vaginal epithelium, improving pH and elasticity.

  • Contraindications:

    • Minimal risk with localized use, avoid in estrogen-dependent cancer.

  • Drug Interactions:

    • Minimal due to low systemic absorption.

  • Side Effects:

    • Minimal; may include local irritation or discharge.

Selective Estrogen Receptor Modulators (SERMs)

  • TAMOXIFEN

    • Indications: Gold standard for ER+ breast cancer; breast cancer prevention in high-risk women.

    • Doses: 20 mg orally once daily.

    • Mechanism of Action: Competitive antagonist in breast; partial agonist in bone.

    • Contraindications: Pregnancy, history of thromboembolism.

    • Drug Interactions: CYP2D6 inhibitors reduce efficacy.

    • Side Effects: Hot flashes, endometrial hyperplasia, thromboembolism.

  • RALOXIFENE

    • Indications: Prevention and treatment of postmenopausal osteoporosis.

    • Doses: 60 mg orally once daily.

    • MOA: Agonist on bone, antagonist on breast and uterus.

    • Contraindications: History of thromboembolic events, pregnancy.

    • Side Effects: Hot flashes, leg cramps, thromboembolism risk.

Clomiphene Citrate

  • Classification: SERM; ovulation stimulant.

  • Mechanism of Action:

    • Blocks estrogen receptors in the hypothalamus, preventing feedback inhibition of gonadotropin release.

  • Indications: Ovulatory dysfunction.

  • Contraindications: Pregnancy, undiagnosed abnormal bleeding; liver disease.

  • Side Effects: Hot flashes, visual disturbances, ovarian enlargement.

Fulvestrant

  • Classification: SERM.

  • Mechanism of Action: Pure antagonist; degrades estrogen receptors.

  • Indications: ER-positive, HER2-negative advanced breast cancer.

  • Contraindications: Hypersensitivity, pregnancy, breastfeeding.

  • Side Effects: Injection site reactions, gastrointestinal effects.

Aromatase Inhibitors

  • Classification: Block estrogen production.

  • Subtypes: Nonsteroidal (Anastrozole, Letrozole) and steroidal (Exemestane).

  • Mechanism of Action: Inhibit aromatase, reducing estrogen levels in postmenopausal women.

  • Indications: Breast cancer treatment.

  • Contraindications: Premenopausal women unless combined with ovarian suppression.

  • Side Effects: Hot flashes, musculoskeletal pain, bone health issues.

Conclusion

  • Importance of Awareness: Understanding these drugs is crucial for managing hormonal therapies, contraceptive care, and oncological treatments effectively.

Progestins

Overview of Progestin Derivatives

  • Progestins are synthetic counterparts of endogenous progesterone.

  • Classification:

    • Pregnanes: Medroxyprogesterone acetate, Megestrol acetate.

    • Estranes: Norethindrone, Lynestrenol.

    • Gonanes: Levonorgestrel, Desogestrel.

Mechanism of Action

  1. Nuclear Receptor Binding: Progestins bind to progesterone receptors, regulating gene transcription.

  2. Hypothalamic-Pituitary Axis: Suppress GnRH, reducing FSH and LH from the anterior pituitary.

  3. Peripheral Effects:

    • Transform proliferative endometrium into a secretory one.

    • Thickens cervical mucus, slowing tubal motility.

Indications

  • Contraception: Various forms including OCPs.

  • Hormone Replacement Therapy (HRT): To prevent endometrial hyperplasia with estrogen.

  • Other Uses: Management of endometriosis, abnormal uterine bleeding.

Drug Interactions and Side Effects

  • Drug Interactions: CYP3A4 inducers/inhibitors, other hormonal agents.

  • Common Side Effects: Menstrual irregularities, breast tenderness, weight gain, mood changes.

Antiandrogens

Classification and Mechanism

  • Antiandrogens block androgen action or inhibit their synthesis.

  • Indications: Used in prostate cancer, hirsutism, acne treatment.

Side Effects

  • May include hot flashes, liver toxicity, gynecomastia, and mood swings.

Conclusion

  • Drugs targeting hormone receptors play critical roles in the treatment of various endocrine disorders, emphasizing the importance of individualized patient care in hormonal therapies.

Recombinant and Miscellaneous Therapies

  • Discusses the relevance of ongoing research and the potential for new therapies in the future, outlining the ever-evolving landscape of hormonal treatments.